ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

NCI Offers Chlorozotocin

November 18, 1977

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

Army of Women, caBIG To Collaborate.

August 7, 2009

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992